Natural killer (NK) cells show differential functionality based on their capability of binding to self-MHC consistent with licensing. Here we show in vivo confirmation of the physiologic effects of licensing with differential effects of NK subsets on anti-murine cytomegalovirus (anti-MCMV) responses after syngeneic hematopoietic stem cell transplantation (HSCT) or regulatory T-cell (Treg) depletion. After HSCT, depletion of licensed NK cells led to far greater viral loads in target organs early after infection compared with nondepleted and unlicensed depleted mice. There was a preferential expansion of licensed, C-type lectin-like activating receptor Ly49H+ NK cells with increased IFNγ production after infection in nondepleted mice post-HSCT and after Treg depletion. Adoptive transfer of licensed NK subsets into immunodeficient hosts provided significantly greater MCMV resistance compared with transfer of total NK populations or unlicensed subsets. In non-HSCT mice, only concurrent depletion of Tregs or TGF-β neutralization resulted in detection of NK licensing effects. This suggests that licensed NK cells are the initial and rapidly responding population of NK cells to MCMV infection, but are highly regulated by Tregs and TGF-β.
immunity | innate immune system | virology | education | arming N atural killer (NK) cells are lymphocytes without recombinant antigen receptors involved in cytokine production and non-MHC restricted cytotoxicity toward virally infected and transformed cells (1) . Their activation is controlled by the presence and triggering of a wide range of inhibitory and activating receptors (2) . One family of these receptors, the Ly49s, are a diverse class of C-type lectin-like activating and inhibitory receptors that bind to MHC class I and similar ligands and are found in mice and known to help modulate NK cell cytotoxicity. The functional analog in humans, the killer Ig-like receptors (KIRs), have dissimilar structures but similar binding capabilities to MHC as Ly49s (3, 4) . The inhibitory receptors in these families bind to specific MHC class I molecules, with each receptor having a higher affinity for one of the many MHC haplotypes, including those for self as well as nonself (5) .
The presence of NK cell subsets that express Ly49s or KIRs specific for self-MHC or nonself-MHC suggests that these different receptors play important regulatory roles with regard to function. Mouse NK cells expressing Ly49 inhibitory receptors that bind to self-MHC (known as "licensed" NK cells) exhibit increased functional responses in vitro (6) (7) (8) , a phenomenon also demonstrated in human NK cells and KIRs (9, 10) . In contrast, NK cells expressing Ly49 receptors that are not capable of binding to self-MHC are hyporesponsive and termed "unlicensed" (6) . The phenomenon of NK subset licensing has been primarily observed in studies using in vitro stimulation responses (6) (7) (8) . In vivo evidence for NK subset licensing has been limited to studies demonstrating their differential ability to resist bone marrow allografts (7, 11) , enrichment of licensed NK cells during development (12) and CMV (13) , and MHC-disparate cell rejection (14) . Questions regarding a physiological role for licensing have persisted because of a lack of in vivo evidence demonstrating differential pathogen or tumor resistance.
Contrary to the licensing paradigm, a recent report concluded that depletion of the unlicensed and not the licensed NK cell subset resulted in significantly impaired anti-murine cytomegalovirus (anti-MCMV) responses (15) . To help explain the disparate findings, we studied functional differences between the licensed and unlicensed NK cells shortly after hematopoietic stem cell transplantation (HSCT). In this setting, NK cells are the first lymphocytes to repopulate after HSCT (16, 17) and the primary immune defense against tumors and viruses. Additionally, it is important to identify populations of NK cells that are functionally more potent because the appearance of opportunistic infections during the lymphopenic state after HSCT is of particular concern (18) . The HSCT setting thus provides an environment where potential functional differences between licensed and unlicensed NK cells may be most pronounced and licensing might be clinically significant for patients who undergo HSCT.
In contrast to previously published observations in resting mice, we observed that the licensed NK cell subsets expanded and demonstrated greater protection against MCMV after syngeneic HSCT, especially early after infection. We also show similar results to the HSCT model following regulatory T-cell (Treg) depletion or TGF-β neutralization in resting mice. Under these conditions, licensed NK cells have a significantly greater protective role than the unlicensed cells and mirrored our HSCT studies, illustrating a preferential regulatory role of Tregs toward licensed NK cells. Furthermore, greater MCMV protection is shown following adoptive transfer of NK cells enriched for the licensed population compared with the protection from total NK cell or unlicensed NK cell transfer. Thus, licensed NK cells provide strong antiviral protection during early stages of infection, but are regulated and suppressed by Tregs and TGF-β. (Fig. S1 ). The NK cell compartment at this time point (day 10 post-HSCT) is shown for different strains before MCMV infection (Fig. S1D ). Viral loads were assessed 7 d after infection (day 17 post-HSCT). Surprisingly, and in contrast to the infected non-HSCT mice (15) , depletion of the licensed NK cell subset resulted in significantly greater liver viral loads compared with depletion of the unlicensed subsets ( Fig. 1 A and  B) . Ly49A depletion reflected Ly49G2 depletion results in terms of viral load corresponding to similar binding affinities of the two receptors ( Fig. S2 A and B) . However, because the Ly49A population is a relatively small fraction of the total NK population ( Fig. S2 C and D) , the depletion of the Ly49A+ population ( Fig.  S2E for depletion controls) did not greatly impact the viral loads ( Fig. S2 A and B) . The viral loads also corresponded with weight loss and liver pathology in the mice (Fig. S3) .
Results

Depletion of Licensed NK Cells Results in Significantly Impaired
To determine if there were any discernible differences among the different NK populations in a setting where both H-2 b and H-2 d molecules were present (and thus both Ly49G2 and Ly49C/I subsets would be licensed), B6D2F1 hybrid (H-2 b × H-2 d ) mice were used. No discernible differences in viral load (Fig. 1C ) or weight change (Fig. S3I ) with depletion of either subset of NK cells were observed, suggesting that licensing of both NK subsets did indeed occur. Depletion of both Ly49G2+ and Ly49C/I+ subsets resulted in viral loads equivalent to total NK depletion, demonstrating the loss of the anti-MCMV response by the licensed NK cells (Fig. 1C) . These data indicate that NK cell licensing can be observed in MCMV resistance following syngeneic HSCT and corroborate our previous studies regarding NK cell licensing in the allogeneic HSCT setting (11) .
Licensed Ly49+ NK Subsets Predominantly Protect Early After MCMV Infection Following HSCT, Whereas Unlicensed NK Subsets Have a Delayed Protective Role. At early time points after infection, depletion of the licensed population resulted in similarly increased viral titers as total NK depletion. Interestingly, the differences between licensed and unlicensed NK depletion on liver viral titers decreased during the time course of the infection, and no differences were observed on day 14 postinfection (Fig. 1D ). Viral loads decline in most organs by days 7-10, but have a more persistent localization in the salivary gland for weeks to months postinfection (19, 20) . In accordance with this persistence, viral titers were still significantly greater with licensed NK depletion in the salivary gland even at the later time points (Fig. 1E ). These findings highlight the kinetic differences between licensed and unlicensed cells whereby the licensed NK cells respond quickly, while the unlicensed mediate viral resistance at a much slower rate.
Prior in vivo activation of the NK cells with polyinosinic:polycytidylic (poly I:C) eliminated this early superiority of the licensed subset in resistance to MCMV by increasing the ability of the unlicensed subset to resist the infection early compared to licensed cells (Fig. S4 ). No differences in IFNγ production by the different subsets were observed after poly I:C treatment in these studies ( Fig. S4 B-D) This demonstrates that the licensing advantage can be overridden with prior activation of the unlicensed population, as has been previously shown in vitro (6, 21) and in vivo (11) .
Preferential Expansion of Licensed and not Unlicensed Ly49H+ NK Cells
After MCMV Infection Post-HSCT. Ly49H is an activating receptor on NK cells and has been shown to provide strong anti-MCMV capabilities with direct recognition of the MCMV glycoprotein m157 leading to preferential expansion (22) (23) (24) . Upon gating for CD3-NK1.1+Ly49H+ NK cells for expression of Ly49G2 versus Ly49C/I, a preferential expansion of only the licensed NK cell subset was observed after infection ( (Fig. 3 A and D) . Licensed NK cells also exhibited greater mean fluoresence intensity (MFI) for IFNγ associated with increased production of IFNγ ( Fig. 3 B and E) . A significant decrease in the fold increase of IFNγ, as detected by RT-PCR, also resulted when the licensed population was depleted. The depletion of the unlicensed population, however, produced minimal effects on the fold increase of IFNγ (Fig. 3 C and F) . In agreement with the viral load data, no discernible differences in IFNγ staining (Fig. 3 G and H) or mRNA expression (Fig. 3I) were observed as a result of depletion of the different Ly49 subpopulations in B6D2F1 mice. IFNγ was important for the protective effects of NK cells as the viral titers were greater in the recipients receiving IFNγ-deficient donor cells from IFNγ knockout mice (GKO) compared with WT donors. The magnitude of difference between licensed and unlicensed NK cell-depleted groups was greater with GKO donors (Fig. 3J) . However, because the NK cells were still capable of providing anti-MCMV protection, there are most likely other factors and mechanisms involved as well, including perforin/ granzyme release and other cytokines (29) . Similar expansion of licensed Ly49H+ NK cells after infection was also seen with GKO donors, indicating that it was the loss of IFNγ that resulted in increased viral loads (Fig. 3K) .
Adoptive Transfer of Licensed NK Cells Provides Greater MCMV Protection than Unlicensed or Total NK Populations. To confirm the NK cell resistance pattern observed with cell-depletion studies, we used NOD.SCID.IL-2γ receptor knockout mice that have no functional lymphocytes, including NK cells, and transferred purified NK cells from mice depleted of the opposite subset. Transfer of the enriched NK cells for the licensed population resulted in significantly reduced viral loads in the liver, compared with both transfer of whole NK populations or just the unlicensed population (Fig. 4A) . There was also a greater expansion of Ly49H+ NK cells from the adoptively transferred licensed cells compared with the other groups, consistent with the HSCT data (Fig. 4B) . This confirmed the significance of the (30, 31) . We ascertained if Tregs were responsible for differences observed with regard to licensing effects in HSCT versus non-HSCT mice upon MCMV infection as lethal irradiation in HSCT markedly depletes T cells. In agreement with this, depletion of Tregs in non-HSCT mice using anti-CD25 followed by NK subset removal (Fig. S1 A and C) and infection resulted in a similar pattern of licensing in all tested mouse strains, as assessed by viral load in livers (Fig. 5 A-C) . This explains the differential effects reported in resting infected mice (15) . Unlicensed subset depletion resulted in slightly greater viral loads in resting mice, whereas in CD25-depleted mice, the opposite effect was observed as the licensed subset depletion resulted in far greater viral loads, suggesting regulation of licensing at least partially by Tregs (Fig. 5C) . Expansion of the licensed Ly49H+ NK cells and contraction of unlicensed NK cells occurred after MCMV infection, analogous to the HSCT model, following anti-CD25 treatment (Fig. 5 D and E) . Interestingly, non-HSCT and non-CD25 depleted mice showed an expansion of Ly49H+Ly49G2+ NK cells regardless of MHC background in response to MCMV (Fig. S6) in agreement with previous studies (17) . Greater percentages of IFNγ+ licensed NK cells (Fig. 5 F and I ) with higher IFNγ MFIs (Fig. 5 G and J) were observed after Treg depletion. This was also associated with a reduction in IFNγ mRNA expression with licensed subset depletion ( Fig. 5 H and K) and significantly exacerbated liver abnormalities (Fig. S3 D and E) . Immunosuppression by Tregs has been shown to be in part mediated by TGF-β (31). In vivo TGF-β blockade resulted in an identical pattern of NK licensing in response to MCMV infection analogous to HSCT or anti-CD25 depletion (Fig. 5C ). These data suggest that Tregs and TGF-β are responsible for suppressing NK cell licensing effects during MCMV infection.
We next determined if Treg depletion of residual Tregs remaining after HSCT (32) would further enhance the viral load differences between licensed and unlicensed depleted mice. The overall viral titers in C57BL/6 (H-2 b ) mice were significantly reduced using anti-CD25 after HSCT in all groups other than NK1.1 depleted mice (Fig. 5L) . However, the fold differences in viral titers between C57BL/6 (H-2 b ) mice depleted of licensed versus unlicensed cells were significantly greater with anti-CD25 administration than without anti-CD25 post-HSCT (20.62 ± 3.464 and 7.34 ± 2.887, respectively; P value = 0.0422). The Treg population after HSCT and at day 14 after infection (day 24 post-HSCT) were determined, showing recovery of the Treg population at the end of the time course (Fig. S7) . This correlates with the reduced differences in viral loads seen between the licensed and unlicensed NK cell depleted groups (Fig. 1) . The data indicate potential Treg-NK cell interactions may mask licensing effects in vivo.
Discussion
The biological impact of NK cell licensing, although having potentially significant clinical implications, has been controversial due to the lack of in vivo data using viral or tumor models. Previous reports have found the unlicensed population capable of a greater anti-MCMV response in mice (15) and in an antineuroblastoma role in humans based on missing KIR ligands (33, 34) . However, others have shown in vivo effects of NK licensing in BMC rejection models (7, 11) . In humans, NK cells with KIRs capable of binding to self-HLA and expressing the C-type lectin activating receptor NKG2C significantly expanded post-HSCT with CMV reactivation compared with unlicensed NK cells (35) . The discrepancies in these reports regarding the capabilities of licensed versus unlicensed NK cells may stem from differences in the models and disease processes observed. The immunocompetence and treatments that the organism undergoes may have dramatic effects on the process and regulation of licensing and NK ontogeny.
The recent paper showing that unlicensed NK cells play a greater role in the response to neuroblastoma with monoclonal antibodies against the disialoganglioside GD2 than licensed NK cells (33) highlights the potential regulation and kinetics of the licensed population of NK cells. The licensed subset may have a stronger response early on that becomes inhibited or exhausted. The unlicensed cells may mount a stronger response later due to the activation that occurs along with a lack of inhibition from MHC I.
Our studies show that using T and NK cell-depleted HSCT or Treg depletion models where NK cells are potentially less suppressed were indeed key parameters for observing licensing effects. We observed evidence of licensing through expansion of the licensed Ly49H+ NK cells capable of a strong anti-MCMV response post-HSCT across different MHC class I haplotypes. These licensed NK cells predominantly coexpressed NKG2A, suggesting an additive effect of self-recognition by receptors leading to improved responses by the cell. NKG2A expression may play a significant role in NK activity with increased IFNγ production by licensed NKG2A+ cells. The Ly49G2/C/I/A− population may contribute to the antiviral defense as well, but was shown to behave similarly to the unlicensed population in terms of IFNγ production. Although the viral titers fluctuate slightly possibly due to altered virulence of the virus, the overall patterns of licensing remain consistent throughout all experiments. These results show evidence of licensing in a pathologic setting in vivo that can be used clinically.
This effect of NK licensing is in stark contrast to previous results obtained in non-HSCT adult and neonatal mice (15) . The presence of Tregs in non-HSCT and neonatal (36) mice may explain the differences between our findings and the previously published data (30) . Although anti-CD25 does not completely remove Tregs, it does block the function of the remaining Tregs, allowing for a setting of reduced and nonfunctional Tregs (37) . Recent findings have shown the up-regulation of CD25 in activated NK cells after MCMV infection (38) . Therefore, it is possible that the differences observed after CD25 depletion are due to the reduced number of activated NK cells. However, the A B MCMV viral titers and NK populations obtained after TGF-β blockade were similar to results after anti-CD25 depletion, suggesting that Tregs are responsible for the preferential suppression of licensed NK cells. Highly active and functional NK cells could lead to auto-reactivity or a long-lasting inflammatory status, which needs to be suppressed by regulatory cells. Although no toxicities or abnormalities in the mice following Treg depletion or TGF-β blockade were observed following MCMV infection, it is possible that in different viruses or at higher viral doses Treg depletion could result in high toxicity due to stronger immune responses.
There appear to be fundamental differences in the kinetics between the licensed and unlicensed NK populations that could contribute to Tregs preferentially suppressing licensed NK cells initially. Our data indicate that the licensed NK population is capable of mounting a rapid antiviral response early postinfection, whereas the unlicensed population takes longer, possibly due to the need to reach an activation threshold with sufficient stimulation as evidenced by the lack of a difference between subset depletion with prior poly I:C activation. This is analogous to unlicensed NK cells being capable of BMC rejection, although much less efficiently than licensed (11) . An increased expansion of licensed NK cells is also observed upon depletion of the unlicensed. Homeostatic proliferation may contribute to this increased expansion to fill the niche left by the depletion, but a similar degree of expansion of the unlicensed cells upon licensed cell depletion is not observed. Additionally, when an enriched population of NK cells for either subset is injected into mice, the licensed cells showed greater expansion, indicating that the expansion differences observed are due to a licensing effect and not only to homeostatic proliferation.
Recent work has shown that the Ly49G2 high NK cells initially predominate after HSCT independently of MHC haplotype (17) . This would presumably place the licensed subset (Ly49C/I+) at a disadvantage in H2 b strain mice. However, we observed that the licensed population was still able to mount a strong anti-MCMV response, highlighting the significant functional effects of licensing.
Interestingly, because Ly49G2 expression also correlates with licensing in H2 d strains, we observed a greater anti-MCMV response compared with H2 b strains as reflected by viral loads due to this initial Ly49G2+ licensed cell repopulation. Additionally, the initial studies that looked at binding affinities of the different Ly49s with the MHC I ligands showed some Ly49 receptors, such as Ly49I and Ly49C, capable of binding to multiple MHC I ligands (5) . However, the strength of the binding affinity appears to play a critical role in licensing because these populations do not play as significant an antiviral role in H-2 d mice in terms of expansion, viral control, and IFNγ production. Licensing may also be more of a gradient with the degree of binding and the number of receptors binding to self all regulating the functional activity of the cells (25) as demonstrated by the IFNγ production being greater from licensed NK cells that coexpress NKG2A.
The in vivo data presented showing the role of licensing in MCMV models highlights the significance of the initial in vitro studies on licensing (6, 7) and illustrates that licensing is a complex process that has many levels of regulation. The time frame of the immunological challenge, the immune cells involved, the degree of activation of the NK cells, and the challenge itself all play a role in how licensing affects the NK cell response. The effects of NK cell licensing may be of particular importance post-HSCT where the T-cell compartment is deficient and there is concern for viral reactivation and/or tumor relapse. Adoptive transfer of licensed, highly active NK cells in this setting may be of clinical utility in helping to overcome these issues, consistent with the demonstration of the benefit of NK transfer in previous clinical trials (39, 40) . Additionally, removal of Tregs or blockade of TGF-β may be used to further increase the efficacy of licensed NK cell transfer in cancer. Importantly, the data demonstrate the complexity of the immunoregulation existing between NK cells and T cells. Manipulation of this network of interaction between Tregs and NK subsets can lead to improved immunotherapies using the NK subsets of greatest effector function for a given immunological situation. Flow cytometry surface and intracellular staining on harvested spleens was conducted as previously described (17) (SI Materials and Methods). Quantification of MCMV and determination of mRNA levels for cytokines using real-time PCR was performed as previously described (41) (SI Materials and Methods). Immunofluorescence studies were conducted using a recombinant MCMV derived from the Smith strain that expresses EGFP (RVG-102). Liver samples were sectioned, stained, and visualized 7 d after infection as previously described (42) (SI Materials and Methods). Adoptive transfer studies are described in SI Materials and Methods.
Statistical Analysis. Statistical significance for viral titers and flow cytometry data were determined by using two-tailed Student's t test and two-or oneway ANOVA with Tukey posttest analysis when appropriate. P values were considered statistically significant when P < 0.05.
